Table 3.
Anti-Spike Antibody Titre |
Anti-Receptor Binding Domain Titre |
Anti-Nucleocapsid Antibody Titre |
|||||||
---|---|---|---|---|---|---|---|---|---|
Beta | 95% CI | p-value | Beta | 95% CI | p-value | Beta | 95% CI | p-value | |
All Patients | |||||||||
Male Sex | 0.383 | 0.142-0.623 | 0.002 | 0.412 | 0.193-0.640 | <0.0013 | 0.314 | 0.120-0.509 | 0.002 |
Age (years) | 0.006 | -0.001-0.013 | 0.095 | 0.008 | 0.001-0.014 | 0.031 | 0.010 | 0.004-0.0160 | 0.001 |
Symptomatic Illness | 1.25 | 0.975 - 1.532 | <0.001 | 1.029 | 0.772-1.286 | <0.001 | 1.020 | 0.796 - 1.244 | <0.001 |
Symptomatic Individuals | |||||||||
Male Sex | 0.137 | -0.202 - 0.479 | 0.448 | 0.1411 | -0.173 - 0.457 | 0.381 | 0.079 | -0.212 - 0.372 | 0.612 |
Age (years) | 0.023 | 0.013-0.033 | <0.0001 | 0.021 | 0.012 - 0.030 | <0.001 | 0.028 | 0.020 - 0.037 | <0.001 |
Time since reported illness (days) | -0.002 | -0.004 - 0.000 | 0.041 | -0.002 | -0.004 - 0.000 | 0.022 | 0.005 | -0.007 - -0.003 | <0.001 |